CDMO

Navigating the Complexities of Microbial and Mammalian Manufacturing

Peter Boman; Helena Pettersson

NorthX Biologics

CDMO

Advancing the Science of Technical and Therapeutic Proteins

Eva-Karin Gidlund, Ph.D.

NorthX Biologics

Expansion

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Benedikt von Braunmühl; Tom Roberts

Rentschler Biopharma SE

Comparability

Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes

Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion

Tanvex CDMO

Biosimilars

Biosimilars: Manufacturing and Supply Chain for Worldwide Patients

Paula Olcese

Biosidus

Biosimilars

Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets

Hugo Sotelo; Marcelo Criscuolo

Biosidus

Biosimilars

Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars

Hugo Sotelo; Marcelo Criscuolo

Biosidus

Biosimilars

Navigating the Global Regulatory Landscape for Biosimilars

Veronica Grimoldi

Biosidus

Chronic Diseases

Transforming the Management of Chronic Diseases with Biosimilars

Hugo Sotelo; Jorge Catella

Biosidus

Synthetic DNA

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

Tom Merritt, Ph.D.

Touchlight

Digitalization

Overcoming Development Challenges with Digital Solutions

Wheeler Bio

Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

April Stanley, MS MBA

Nice Insight

Advanceability

Right from the Start: Designing Advanceable Formulations and Processes at Phase I

Serán Bioscience

Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

Expanded CDMO Capabilities

On the Journey to Support Drug Developers With End-to-End Outsourcing

Michelle Hall

Mikart

API

Enhanced Solubility through API Processing: Salt and Cocrystal Formation

Thomas Briel, Ph.D.; David Luedeker, Ph.D.

MilliporeSigma